Maia Biotechnology, INC. DEFA14A Filing
Ticker: MAIA · Form: DEFA14A · Filed: Apr 7, 2026 · CIK: 0001878313
Sentiment: neutral
Filing Stats: 127 words · 1 min read · ~1 pages · Grade level 14.6 · Accepted 2026-04-07 09:04:09
Filing Documents
- ny20065433x2_defa14a.htm (DEFA14A) — 8KB
- ny20065433x2_pc01.jpg (GRAPHIC) — 505KB
- ny20065433x2_pc02.jpg (GRAPHIC) — 309KB
- 0001140361-26-013502.txt ( ) — 1129KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Rule 14a-ll (c) or Rule 14a-12 MAIA Biotechnology, Inc. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.